SCR-LIP-000193 · Claim · machine-readable JSON →
The S2k lipedema guideline defines lipedema as painful, disproportionate, symmetrical adipose distribution occurring almost exclusively in women, and states that diagnosis is clinical, requiring disproportion plus concomitant symptoms (pain), while morphological staging should NOT be used as a measure of severity, the 'nodular' criterion should not be used for diagnosis, and no instrument (duplex, ultrasound, MRI, lymphoscintigraphy, laboratory tests) can confirm lipedema (they serve only for differential diagnosis).
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- very low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- S2k guideline lipedema — Faerber et al. (2024) ✓ verified — refining · review · 2024 · reading confidence: high
“Rec 2.2–2.5: Diagnóstico exige disproproção + sintomas concomitantes; estadiamento morfológico NÃO deve ser usado como medida de gravidade; critério 'nodular' não deve ser usado para diagnóstico”
This consensus guideline directly addresses diagnostic criteria and explicitly refines/critiques the reliability of stage/type classification systems, recommending against using morphological staging as a severity measure and against the no [grade capped moderate->very_low per curated Oxford N6]
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000022